Predicting risk in left ventricular non-compaction
Part of Heart & circulation clinical trials.
This study is for adults who have been diagnosed with a condition called left ventricular non-compaction (LVNC). It aims to find out what might predict future health problems in people with this condition. By joining, you can help researchers learn more about LVNC and improve care for others like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with left ventricular non-compaction (LVNC).
- Your LVNC diagnosis was made between 2010 and 2020 (if joining the retrospective group).
- You are 18 years old or older.
- You do not have any other heart muscle disease (cardiomyopathy) that is linked to a genetic mutation you carry.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at different types of heart muscle diseases that are not caused by blocked arteries (non-ischemic cardiomyopathies). It aims to better understand how to diagnose, predict outcomes, and treat these conditions by gathering information from many patients over time.
This study is for people with a rare heart condition called non-compaction of the ventricular myocardium, where the heart muscle has a spongy appearance. It aims to find better ways to predict risks and prevent complications.
This study uses heart MRI scans to predict who might develop dangerous heart rhythms. It's for people with certain types of non-ischemic heart disease who have already had an MRI with contrast.
This registry study collects information, blood samples, and MRI images from people with non-ischemic cardiomyopathy (a heart muscle disease not caused by blocked arteries). By joining, you help researchers better understand the condition and find new ways to diagnose and treat it.
This study looks at how the heart's electrical signals can predict sudden cardiac arrest in people with a weakened heart muscle. It may help doctors identify who is at highest risk.
This trial tests an experimental drug called NVC-001 for people with a specific genetic heart condition (LMNA-related dilated cardiomyopathy) that causes the heart to become weak and enlarged. The goal is to see if the drug can help improve heart function.
Hear when a new Left Ventricular Noncompaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.